Mohankumar Doraiswamy
Researcher
Also affiliated: Texas Tech University (2021); Newark Beth Israel Medical Center (2018); Mercy Medical Center (2022–2024); Monmouth Medical Center (2018–2024); University of Arizona (2018); John Peter Smith Hospital (2026); Smith Family (2023); Cooper Green Mercy Hospital (2022–2024); The Ohio State University Wexner Medical Center (2020–2023); Mercy Hospital (2023); CHI Health Mercy Council Bluffs (2022–2023); Mercy Hospital (2024); Smith Clinic (2026); Arizona Oncology (2018); Mercy Health (2023); Mercy Hospital (2022–2024); The Ohio State University (2020–2024); Rogers (United States) (2024); Texas Tech University Health Sciences Center (2021)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mohankumar Doraiswamy's research focuses on medical case studies and retrospective analyses within nephrology and transplant medicine. His work has investigated kidney transplantation amidst the COVID-19 pandemic, examining modifications to immunosuppression regimens. Doraiswamy has also studied readmissions following COVID-19 related hospitalizations, specifically focusing on gastrointestinal complications. Other areas of his research include the overview of pregnancy in solid-organ transplantation, and the diagnostic challenges of glomerular diseases like immunotactoid glomerulonephritis and IgA nephropathy. He has also explored rare oral lesions in kidney transplant recipients caused by cytomegalovirus and the pandemic's effect on national hospitalizations for acute hyperglycemic complications. Doraiswamy has published 39 papers, holds an h-index of 3, and has accumulated 32 citations.
Metrics
- h-index: 3
- Publications: 39
- Citations: 34
Selected Publications
-
Malignant Catatonia From Paliperidone Withdrawal With Successful Pharmacological Treatment: A Diagnostic and Therapeutic Challenge (2026)
-
Unexpected Consequences: A Rare Mycotic Pseudoaneurysm After Salmonella Gastroenteritis (2025)
-
Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19 (2024)
-
Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies (2023)
-
A Rare Case of Recurrent Immunotactoid Glomerulonephritis (2023)
Collaboration Network
Top Collaborators
- A Rare Case of Recurrent Immunotactoid Glomerulonephritis
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- A Rare Case of Recurrent Immunotactoid Glomerulonephritis
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Isolated arterial mucoid intimal thickening lesion in early post‐transplant kidney allograft biopsies
- Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
- Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
- Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
Similar Researchers
Based on overlapping research topics